Welcome to our dedicated page for Sealed Air news (Ticker: $SEE), a resource for investors and traders seeking the latest updates and insights on Sealed Air stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Sealed Air's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Sealed Air's position in the market.
Atlas Holdings has announced the sale of NPX One, a top manufacturer of polystyrene trays for fresh protein in the U.S., to Breck Partners. The terms of the transaction were not disclosed. NPX One, previously known as Novipax, was acquired by Atlas in 2015 and has now been sold after almost a decade. The company boasts a strong customer base and a history of innovation in food tray manufacturing.
SEE's comprehensive sustainability approach focuses on environmental responsibility, offering scalable solutions like the AUTOBAG® brand 850S paper system and CRYOVAC® brand offerings. The company also provides digital printing services through prismiq™ and automated carbon footprint solutions, aiming to drive sustainability across the value chain.
SEE reported Q1 2024 results with net sales of $1.33 billion, down 1%, and net earnings of $83 million, up 33%. Adjusted EBITDA was $278 million, up 4%. Cash flow from operations was $125 million, up 141%. The company reaffirmed its 2024 full-year outlook with expectations of net sales in the range of $5.2 to $5.6 billion and Adjusted EBITDA of $1.05 to $1.15 billion.